As World TB Day approaches, Jennifer Hughes, a medical officer working for Médecins Sans Frontières (MSF)  on tuberculosis (TB) South Africa, discusses progress in developing drugs to treat TB. In an article on the organization’s website, she writes, “For the first time in fifty years, new drugs are being developed to treat TB. They represent great strides forward, but they can’t be used in isolation. TB is so powerful that you need a full cocktail of drugs to beat it. The only way to catch up to the new face of this old disease is to find new combinations of drugs that are simple, accessible and more tolerable than current treatment and can be implemented rapidly in countries where DR-TB is rife. … We need governments, donors, pharmaceutical firms and research organizations to walk the extra mile, to help deliver new, shorter and more effective treatment combinations — giving people a chance at a cure, a chance at a life…” (3/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.